Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study
Monika A. Niewczas, Tammy L. Sirich, Anna V. Mathew, et al.
Kidney International (2014) Vol. 85, Iss. 5, pp. 1214-1224
Open Access | Times Cited: 205

Showing 1-25 of 205 citing articles:

Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease
Guoqing Huang, Mingcai Li, Yan Li, et al.
Laboratory Medicine (2022) Vol. 53, Iss. 6, pp. 545-551
Closed Access | Times Cited: 862
Targeting metabolic dysregulation for fibrosis therapy
Xiao Zhao, Jennifer Kwan, Kenneth W. Yip, et al.
Nature Reviews Drug Discovery (2019) Vol. 19, Iss. 1, pp. 57-75
Closed Access | Times Cited: 356
Diagnosis of diabetic kidney disease: state of the art and future perspective
Frederik Persson, Peter Rossing
Kidney International Supplements (2017) Vol. 8, Iss. 1, pp. 2-7
Open Access | Times Cited: 278
The gut–kidney axis
Pieter Evenepoel, Ruben Poesen, Björn Meijers
Pediatric Nephrology (2016) Vol. 32, Iss. 11, pp. 2005-2014
Closed Access | Times Cited: 234
Biomarkers of diabetic kidney disease
Helen M. Colhoun, M. Loredana Marcovecchio
Diabetologia (2018) Vol. 61, Iss. 5, pp. 996-1011
Open Access | Times Cited: 222
Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis
Hao Ding, Lei Jiang, Jing Xu, et al.
AJP Renal Physiology (2017) Vol. 313, Iss. 3, pp. F561-F575
Open Access | Times Cited: 195
Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes
Andrzej S. Królewski, Jan Skupień, Peter Rossing, et al.
Kidney International (2017) Vol. 91, Iss. 6, pp. 1300-1311
Open Access | Times Cited: 185
A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population
Peggy Sekula, Oemer-Necmi Goek, Lydia Quaye, et al.
Journal of the American Society of Nephrology (2015) Vol. 27, Iss. 4, pp. 1175-1188
Open Access | Times Cited: 184
Molecular pathways that drive diabetic kidney disease
Samer Mohandes, Tomohito Doke, Hailong Hu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 4
Open Access | Times Cited: 166
Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies
Qiao Jin, Ronald C.W.
Cells (2021) Vol. 10, Iss. 11, pp. 2832-2832
Open Access | Times Cited: 159
Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease
Pedro Pereira, David F. Carrageta, Pedro F. Oliveira, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 4, pp. 1518-1544
Closed Access | Times Cited: 82
Gut-Microbiota-Metabolite Axis in Early Renal Function Decline
Clara Barrios, Michelle Beaumont, Tess Pallister, et al.
PLoS ONE (2015) Vol. 10, Iss. 8, pp. e0134311-e0134311
Open Access | Times Cited: 154
Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus
Yan Xie, Benjamin Bowe, Tingting Li, et al.
Kidney International (2017) Vol. 93, Iss. 3, pp. 741-752
Open Access | Times Cited: 154
Metabolomics and Diabetes: Analytical and Computational Approaches
Kelli M. Sas, Alla Karnovsky, George Michailidis, et al.
Diabetes (2015) Vol. 64, Iss. 3, pp. 718-732
Open Access | Times Cited: 152
Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease
Dan‐Qian Chen, Gang Cao, Hua Chen, et al.
Redox Biology (2017) Vol. 12, pp. 505-521
Open Access | Times Cited: 148
An overview of renal metabolomics
Sahir Kalim, Eugene P. Rhee
Kidney International (2016) Vol. 91, Iss. 1, pp. 61-69
Open Access | Times Cited: 143
Biomarkers of rapid chronic kidney disease progression in type 2 diabetes
Helen C. Looker, Marco Colombo, Sibylle Hess, et al.
Kidney International (2015) Vol. 88, Iss. 4, pp. 888-896
Open Access | Times Cited: 137
Metabolomics and Type 2 Diabetes: Translating Basic Research into Clinical Application
Matthias S. Klein, Jane Shearer
Journal of Diabetes Research (2015) Vol. 2016, pp. 1-10
Open Access | Times Cited: 134
Gut microbiota and diabetes: From correlation to causality and mechanism
Weizheng Li, Kyle B. Stirling, Junjie Yang, et al.
World Journal of Diabetes (2020) Vol. 11, Iss. 7, pp. 293-308
Open Access | Times Cited: 128
Biomarkers of diabetic nephropathy: A 2017 update
Nektaria Papadopoulou‐Marketou, Christina Kanaka‐Gantenbein, Nikolaos Marketos, et al.
Critical Reviews in Clinical Laboratory Sciences (2017) Vol. 54, Iss. 5, pp. 326-342
Closed Access | Times Cited: 115
Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development
Natalia Nowak, Jan Skupień, Adam M. Smiles, et al.
Kidney International (2018) Vol. 93, Iss. 5, pp. 1198-1206
Open Access | Times Cited: 103
Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
Monika A. Niewczas, Anna V. Mathew, Stephanie Croall, et al.
Diabetes Care (2017) Vol. 40, Iss. 3, pp. 383-390
Open Access | Times Cited: 95
Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians
Farsad Afshinnia, Viji Nair, Jiahe Lin, et al.
JCI Insight (2019) Vol. 4, Iss. 21
Open Access | Times Cited: 95
Metabolomics in diabetic complications
Laura A. Filla, James L. Edwards
Molecular BioSystems (2016) Vol. 12, Iss. 4, pp. 1090-1105
Open Access | Times Cited: 92
Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease
Judy Baek, Chenchen He, Farsad Afshinnia, et al.
Nature Reviews Nephrology (2021) Vol. 18, Iss. 1, pp. 38-55
Open Access | Times Cited: 92
Page 1 - Next Page

Scroll to top